ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,473.23
0.77%
Dow Jones
38,778.10
0.49%
US Dollar vs MXN
18.432
-0.56%
Brent Oil
83.715
-0.22%
Bitcoin
65,323.02
-1.75%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Reino Unido
  5. LSE
  6. Mgc Pharmaceuticals Limited (MXC)

  7. Mgc Pharmaceuticals Limited (MXC) Noticias

MXC

Mgc Pharmaceuticals (MXC)

Mgc Pharmaceuticals Limited
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:LSE:MXC
FechaHoraFuenteTítuloSímboloCompañía
03/04/202401:30RNS Regulatory NewsLondon Stock Exchange Notice Suspension - MGC Pharmaceuticals LimitedLSE:MXCMgc Pharmaceuticals Limited
02/04/202409:40RNS Regulatory NewsMGC Pharmaceuticals Limited Change of name to Argent BioPharma LimitedLSE:MXCMgc Pharmaceuticals Limited
28/03/202404:12RNS Regulatory NewsMGC Pharmaceuticals Limited PDMR NotificationLSE:MXCMgc Pharmaceuticals Limited
28/03/202404:07RNS Regulatory NewsMGC Pharmaceuticals Limited Refinancing of Convertible Securities AgreementLSE:MXCMgc Pharmaceuticals Limited
18/03/202403:23RNS Regulatory NewsMGC Pharmaceuticals Limited Results of General MeetingLSE:MXCMgc Pharmaceuticals Limited
29/02/202411:00Alliance NewsAlliance NewsEARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payoutLSE:MXCMgc Pharmaceuticals Limited
29/02/202403:36RNS Regulatory NewsMGC Pharmaceuticals Limited Half-year ReportLSE:MXCMgc Pharmaceuticals Limited
19/02/202410:00RNS Regulatory NewsMGC Pharmaceuticals Limited Update - Application for Admission to TradingLSE:MXCMgc Pharmaceuticals Limited
13/02/202405:54Alliance NewsAlliance NewsIN BRIEF: MGC Pharmaceuticals proposes name change to Argent BiopharmaLSE:MXCMgc Pharmaceuticals Limited
13/02/202404:00RNS Regulatory NewsMGC Pharmaceuticals Limited Dispatch of General Meeting DocumentsLSE:MXCMgc Pharmaceuticals Limited
13/02/202403:01RNS Regulatory NewsMGC Pharmaceuticals Limited Application for Admission to TradingLSE:MXCMgc Pharmaceuticals Limited
13/02/202401:30UK RegulatoryMGC Pharma Rebrands as Argent BioPharma in Strategic TransformationLSE:MXCMgc Pharmaceuticals Limited
31/01/202401:30RNS Regulatory NewsMGC Pharmaceuticals Limited December 2023 Quarter Activity ReportLSE:MXCMgc Pharmaceuticals Limited
11/01/202403:54UK RegulatoryMGC Pharmaceuticals Limited Director/PDMR ShareholdingLSE:MXCMgc Pharmaceuticals Limited
22/12/202303:09UK RegulatoryMGC Pharmaceuticals Limited Company Update & Placing to Raise US$500,000LSE:MXCMgc Pharmaceuticals Limited
19/12/202312:04Alliance NewsAlliance NewsMGC Pharma gets Saudi approval for Covid-19 over-the-counter treatmentLSE:MXCMgc Pharmaceuticals Limited
19/12/202301:57RNS Non-RegulatoryMGC Pharmaceuticals Limited ArtemiC(TM) receives FDA Approval in Saudi ArabiaLSE:MXCMgc Pharmaceuticals Limited
18/12/202303:06RNS Non-RegulatoryMGC Pharmaceuticals Limited Non-Deal Roadshow Presentation December 2023LSE:MXCMgc Pharmaceuticals Limited
01/12/202302:09UK RegulatoryMGC Pharmaceuticals Limited Corporate Update - Board and UK Adviser ChangesLSE:MXCMgc Pharmaceuticals Limited
30/11/202303:08UK RegulatoryMGC Pharmaceuticals Limited Results of Shareholder's Annual General MeetingLSE:MXCMgc Pharmaceuticals Limited
16/11/202307:51UK RegulatoryMGC Pharmaceuticals Limited Holding(s) in CompanyLSE:MXCMgc Pharmaceuticals Limited
08/11/202304:00UK RegulatoryMGC Pharmaceuticals Limited Capital Consolidation and US$7.9m PlacementLSE:MXCMgc Pharmaceuticals Limited
01/11/202311:54Alliance NewsAlliance NewsTRADING UPDATES: Premier Miton sizes up Tellworth InvestmentsLSE:MXCMgc Pharmaceuticals Limited
01/11/202306:30UK RegulatoryMGC Pharmaceuticals Limited Consolidation and New Fund RaisingLSE:MXCMgc Pharmaceuticals Limited
01/11/202306:03UK RegulatoryMGC Pharmaceuticals Limited MGC Secures US$7.9 Million In Firm CommitmentsLSE:MXCMgc Pharmaceuticals Limited
31/10/202304:32UK RegulatoryMGC Pharmaceuticals Limited Dispatch of Annual General Meeting DocumentsLSE:MXCMgc Pharmaceuticals Limited
30/10/202302:16UK RegulatoryMGC Pharmaceuticals Limited September 2023 Quarter Activity ReportLSE:MXCMgc Pharmaceuticals Limited
25/10/202309:16UK RegulatoryMGC Pharmaceuticals Limited Results of Shareholder's General MeetingLSE:MXCMgc Pharmaceuticals Limited
09/10/202304:03UK RegulatoryMGC Pharmaceuticals Limited Date of AGM & Closing Date of Director NominationsLSE:MXCMgc Pharmaceuticals Limited
29/09/202306:26Alliance NewsAlliance NewsEARNINGS: MGC Pharmaceuticals loss widens, Codex eyes acquisitionsLSE:MXCMgc Pharmaceuticals Limited
 Showing the most relevant articles for your search:LSE:MXC

Su Consulta Reciente

USOTC
CENCF
Neotech Metals (QB)
TG
1YS0
Stillfront Group AB
LSE
LE82
Citi Fun 25
USOTC
SMATF
Canadian GoldCamps (PK)
TG
A2R8AJ
Telenor ASA
BMF
FROF32
FROF32 - 01/2032
COIN
GDNCBTC
NASDAQ
PWUPU
PowerUp Acquisition
LSE
44SG
Inter-amer
EU
FRSG00014KO1
SG Issuer Sg Issuer Zc M...
NASDAQ
HBNC
Horizon Bancorp
NASDAQI
WTRUSNR
TSC US Water Security Ne...
LSE
0HJS
Melamin Dd Kocevje
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados